Prostate Cancer is one of the deadliest diseases that can affect older men. Left undetected, Prostate Cancer can lead to death in many cases. Now, a renowned urologist offers his analysis on the prostate procedure undergone by Utah Senatorial candidate and former Presidential candidate Mitt Romney.
So how deadly is prostate cancer? For men over the age of 50, prostate cancer is one of the most deadly forms of cancer. In fact, there are over 1.4 million cases of prostate cancer each year resulting in over 300,000 annual deaths. That is why it is important for men over the age of 50 to be checked for early detection.
In the case of Mitt Romney, the prostate cancer was detected early and a surgical procedure could be performed. For candidate Romney, the procedure was performed at the University of California Hospital at Irvine by Dr. Thomas Ahlering. According to Dr. David Samadi, the procedure was a success and Mr. Romney will be healthy enough to go forward with his Senatorial campaign.
Because prostate cancer is common in older men, many well-known politicians have had prostate procedures performed leading to a full recovery. Some of the politicians who have had prostate procedures performed include former Secretary of State Colin Powell as well as former Presidential candidate John Kerry.
Dr. David Samadi is an ardent advocate of surgery over chemotherapy to treat prostate cancer. In Dr. Samadi’s own words, the survival rate for someone who has a surgical procedure to remove a localized cancerous prostate is 100%. Chemotherapy, on the other hand, can lead to a number of side effects that can harm and potentially kill the person who is being treated.
Additionally, Dr. Samadi states that if chemotherapy is performed and it turns out that cancer has spread, then the five-year survival rate for the patient drops to about 30%. Dr. Samadi also mentioned that chemotherapy could also expose patients to secondary cancer that could affect other organs of the body.
Dr. David Samadi works at Lenox Hill Hospital as the Chairman of Urology as well as the Chief of Robotic Surgery. Dr. Samadi was educated at Stony Brook University where he received a degree in Biochemistry. Afterward, he received his M.D. at Stony Brook School of Medicine. After completing his urology postdoctorate training at Montefiore Medical Center, Dr. Samadi completed his oncology fellowship at Memorial Sloan Kettering Cancer Center.